Skip to main content
. 2018 Apr 16;9:345. doi: 10.3389/fphar.2018.00345

FIGURE 3.

FIGURE 3

Astragaloside IV inhibited translocation of SREBP-1c into the nucleus. Insulin-resistant HepG2 cells treated with AST displayed a lower SREBP-1c fluorescence intensity in the nucleus. AST, astragaloside IV; C, compound C; IR, insulin resistance. Magnification: ×120.